Pharmacotherapy with immunotherapy for the treatment of otolaryngic allergy.
The total management of the patient with inhalant nasal allergy involves the triad of environmental control, pharmacotherapy, and immunotherapy. The latter treatment may not be necessary in all cases, but definitive testing for the responsible allergens may allow proper avoidance measures. Pharmacotherapy and immunotherapy are complementary, not mutually exclusive, and are a major part of the therapeutic armamentarium of the allergist.
Mabry
R L
RL
Department of Otorhinolaryngology, University of Texas Southwestern Medical Center, Dallas.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy / Q000628:therapy*; D007167:Immunotherapy; D013566:Sympathomimetics / Q000627:therapeutic use*
D000305:Adrenal Cortex Hormones; D006634:Histamine H1 Antagonists; D013566:Sympathomimetics; D004205:Cromolyn Sodium